🇺🇸 FDA
Patent

US 11952366

Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases

granted A61KA61K45/06A61P

Quick answer

US patent 11952366 (Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases) held by The Regents of the University of California expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K45/06, A61P, A61P35/00